Login / Signup

A phase 3 randomized clinical trial using a once-weekly glucagon-like peptide-1 receptor agonist in adolescents and young adults with hypothalamic obesity.

Christian L RothFrancisco A PerezKathryn B WhitlockClinton ElfersJack A YanovskiAshley H ShoemakerM Jennifer Abuzzahab
Published in: Diabetes, obesity & metabolism (2020)
GLP-1 RAs are a promising and safe treatment to improve or stabilize HO in children and young adults.
Keyphrases
  • young adults
  • metabolic syndrome
  • insulin resistance
  • type diabetes
  • weight loss
  • high fat diet induced
  • childhood cancer
  • combination therapy
  • body mass index
  • cell proliferation
  • replacement therapy